These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11322493)

  • 1. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death.
    Filigheddu N; Fubini A; Baldanzi G; Cutrupi S; Ghè C; Catapano F; Broglio F; Bosia A; Papotti M; Muccioli G; Ghigo E; Deghenghi R; Graziani A
    Endocrine; 2001 Feb; 14(1):113-9. PubMed ID: 11322493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.
    Pettersson I; Muccioli G; Granata R; Deghenghi R; Ghigo E; Ohlsson C; Isgaard J
    J Endocrinol; 2002 Oct; 175(1):201-9. PubMed ID: 12379504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing peptides and the cardiovascular system.
    Muccioli G; Broglio F; Valetto MR; Ghè C; Catapano F; Graziani A; Papotti M; Bisi G; Deghenghi R; Ghigo E
    Ann Endocrinol (Paris); 2000 Feb; 61(1):27-31. PubMed ID: 10790589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
    Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
    Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.
    Cassoni P; Papotti M; Catapano F; Ghè C; Deghenghi R; Ghigo E; Muccioli G
    J Endocrinol; 2000 Apr; 165(1):139-46. PubMed ID: 10750044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
    Cassoni P; Papotti M; Ghè C; Catapano F; Sapino A; Graziani A; Deghenghi R; Reissmann T; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1738-45. PubMed ID: 11297611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
    Baldanzi G; Filigheddu N; Cutrupi S; Catapano F; Bonissoni S; Fubini A; Malan D; Baj G; Granata R; Broglio F; Papotti M; Surico N; Bussolino F; Isgaard J; Deghenghi R; Sinigaglia F; Prat M; Muccioli G; Ghigo E; Graziani A
    J Cell Biol; 2002 Dec; 159(6):1029-37. PubMed ID: 12486113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure.
    Liantonio A; Gramegna G; Carbonara G; Sblendorio VT; Pierno S; Fraysse B; Giannuzzi V; Rizzi L; Torsello A; Camerino DC
    Endocrinology; 2013 Oct; 154(10):3764-75. PubMed ID: 23836033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
    Huang J; Li Y; Zhang J; Liu Y; Lu Q
    Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences.
    Benso A; Broglio F; Marafetti L; Lucatello B; Seardo MA; Granata R; Martina V; Papotti M; Muccioli G; Ghigo E
    Semin Vasc Med; 2004 May; 4(2):107-14. PubMed ID: 15478030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretagogue binding sites in peripheral human tissues.
    Papotti M; Ghè C; Cassoni P; Catapano F; Deghenghi R; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3803-7. PubMed ID: 11061542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.
    Pang JJ; Xu RK; Xu XB; Cao JM; Ni C; Zhu WL; Asotra K; Chen MC; Chen C
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1063-9. PubMed ID: 14615277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
    Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
    Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
    Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
    Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.
    Bodart V; Bouchard JF; McNicoll N; Escher E; Carrière P; Ghigo E; Sejlitz T; Sirois MG; Lamontagne D; Ong H
    Circ Res; 1999 Oct; 85(9):796-802. PubMed ID: 10532947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.
    Zhang X; Qu L; Chen L; Chen C
    Physiol Rep; 2018 Feb; 6(4):. PubMed ID: 29446246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart.
    Ma Y; Zhang L; Launikonis BS; Chen C
    Endocrinology; 2012 Nov; 153(11):5480-90. PubMed ID: 22948211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
    Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
    Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.